BDBM140221 US8906911, 30
SMILES: CO[C@@H]1COCC[C@@H]1N[C@@H]1C[C@H]2CCC[C@]2(C1)C(=O)N1C[C@@H]2C[C@H]1CN2c1nc(cs1)C(F)(F)F
InChI Key: InChIKey=IRFFFXKBUHDQEI-KWYGVJCUSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-C chemokine receptor type 2 (Homo sapiens (Human)) | BDBM140221 (US8906911, 30) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 831 | -7.71 | 95.5 | n/a | n/a | n/a | n/a | 7.4 | 4 |
AbbVie Inc. US Patent | Assay Description Radioligand binding assays were performed in CHO cells expressing human CCR2B and Galpha±16 coupling protein. All compounds were dissolved in DMSO a... | US Patent US8906911 (2014) BindingDB Entry DOI: 10.7270/Q2BV7FBV | |||||||||||
More data for this Ligand-Target Pair |